The United States will restrict the use of the Johnson & Johnson vaccine

The U.S. Sanitary and Epidemiological Surveillance Authority restricts the use of the Johnson & Johnson vaccine from COVID-19 because of the risk of developing coagulation syndrome.

Source: Interfax-Ukraine.

Details: The recommendations were issued based on an investigation into reported cases of thrombosis after J&J vaccinations.

The U.S. Centers for Disease Control and Prevention previously recommended Pfizer and Moderna vaccines to Americans instead of J&J for thrombosis with thrombocytopenia.

Background: J&J is one of the coronavirus vaccines used in the United States along with Moderna and Pfizer. It requires only one dose, and Moderna and Pfizer need two doses.

According to the CDC, about 18.7 million Americans have been vaccinated against COVID-19 J&J. Moderna vaccines vaccinated 217.5 million, Pfizer – 340.6 million.

In Ukraine, the J&J vaccine has been certified, but it has not been widely vaccinated.

The United States will restrict the use of the Johnson & Johnson vaccine

Leave a Reply

Your email address will not be published.